Intellipharmaceutics International Inc (IPCIF) Return on Assets ROA from the fourth quarter of 2023 to fourth quarter of 2023 and for the year 2023, Average High and Low, Fundamental Ratios from Nov 30 2022 to May 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Intellipharmaceutics International Inc   (IPCIF)


Intellipharmaceutics International Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Intellipharmaceutics International Inc 's ROA in the fourth quarter of 2023?
Intellipharmaceutics International Inc recorded a cumulative net loss of $-6 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -82.46%.

However, within the Healthcare sector 1216 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from to 6246.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Nov 30 2022)
IV. Quarter		 0
III. Quarter		 (Aug 31 2023)
III. Quarter		 0
II. Quarter		 (May 31 2023)
II. Quarter
Y / Y Total Assets Change 1.05 % 297.9 % 475.6 % -1.23 % -4.96 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -6 -3 -4 -2 -1
Return On Assets (TTM) -82.46 % -43.44 % -62.23 % -47.95 % -28.89 %
IPCIF's Total Ranking # 6246 # # # #
Total Assets (TTM) in million 7 7 7 7 7
Seq. Total Assets Change 2.5 % 2.69 % -6.55 % 2.73 % 303.64 %
Seq. Net Income Change - - - - -

IPCIF's 5 Years Annual ROA >> Back to IPCIF Management Effectiveness >> Compare IPCIF ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 596
Sector # 1217
Overall # 6036

Return On Assets Statistics
High Average Low
245.43 %
-131.24 %
-262.47 %
(Nov 30 2020)   (Nov 30 2013)





Financial Statements
Intellipharmaceutics International Inc 's Assets $ 7 million IPCIF's Balance sheet
Intellipharmaceutics International Inc 's Income $ -3 million Quarterly IPCIF's Income Statement
IPCIF's Income by Division See IPCIF's Income by Division



Annual Return On Assets (Nov 30 2022)
FY 2023		 (Nov 30 2020)
FY 2021		 (Nov 30 2020)
FY 2020		 (Nov 30 2019)
FY 2019		 (Nov 30 2018)
FY 2018
Y / Y Total Assets Change -83.67 % -4.5 % 13.33 % -49.36 % 49.71 %
Total Assets in million 1 8 8 7 14
Y / Y Net Income Change - 51.73 % - - -
Net Income in million -3 5 3 -8 0
Annual Return On Assets -225.87 % 65.61 % 41.29 % -111.57 % 0 %

IPCIF's 5 Years Annual ROA >> Back to IPCIF Management Effectiveness >> Compare IPCIF ROA to its Competitors



More Return On Assets Ratios
IPCIF's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IPCIF's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IPCIF's Competitors
Subscribers only: Roa for Intellipharmaceutics International Inc 's Suppliers
Subscribers only: Return On Assets for IPCIF's Customers

You may also want to know
IPCIF's Roi IPCIF's Inventory Turnover Ratio IPCIF's Growth Rates IPCIF's Dividend Comparisons
IPCIF's Profitability Ratios IPCIF's Asset Turnover Ratio IPCIF's Dividend Growth
IPCIF's Roe IPCIF's Valuation Ratios IPCIF's Financial Strength Ratios IPCIF's Dividend Payout Ratio



Companies with similar Return On Assets at Nov 30 2022, within Healthcare Sector ROA

Date modified: 2026-09-12T06:20:57+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.